GlassScriptPhysician profile
David S Bromet
NPI 1841250958
$12,815.58
in general payments reported to CMS, 2019-2025
38 companies · $5,295 in 2025
The $5,295 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,702 · 2020: $336 · 2021: $395 · 2022: $788 · 2023: $323 · 2024: $977 · 2025: $5,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,722 · Travel and Lodging: $2,836 · Education: $36.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,721.99 |
| Travel and Lodging | $2,836.07 |
| Education | $36.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,462.93 | 2024-2025 | Venaseal, Closurefast, Turbohawk |
| Penumbra, INC. | $2,392.33 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,352.69 | 2019-2023 | |
| Terumo Medical Corporation | $1,117.57 | 2019-2021 | |
| Abbott Laboratories | $934.14 | 2021-2025 | Cardiomems, Diamondback Peripheral |
| E.R. Squibb & Sons, L.L.C. | $588.56 | 2023-2025 | Eliquis, Camzyos, Abilify |
| Abiomed | $437.34 | 2019-2025 | Impella |
| Boston Scientific Corporation | $250.65 | 2023-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Heartflow, INC. | $194.16 | 2024-2025 | |
| Stryker Corporation | $179.86 | 2025 | Artix Mt, Inthrill Thrombectomy Catheter, Flowtriever |
| Astrazeneca Pharmaceuticals LP | $168.88 | 2022-2025 | Wainua, Farxiga |
| Esperion Therapeutics, INC. | $163.86 | 2020-2025 | Nexletol |
| Cardiva Medical, INC. | $162.55 | 2023 | Cardiva Vascade 6/7f Vcs |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.71 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $154.88 | 2024-2025 | Verquvo |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $110.54 | 2021-2022 | |
| Ge Healthcare | $107.65 | 2025 | |
| Novartis Pharmaceuticals Corporation | $107.31 | 2024-2025 | |
| Bridgebio Pharma, INC. | $94.61 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $86.62 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $68.52 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.77 | 2024-2025 | Lifevest |
| Pfizer INC. | $45.53 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.69 | 2021-2024 | Xarelto |
| Amgen INC. | $42.21 | 2024 | Repatha |
| Intuitive Surgical, INC. | $37.27 | 2024 | |
| Recor Medical INC | $36.51 | 2025 | Paradise Ultrasound Renal Denervation System |
| Alnylam Pharmaceuticals INC. | $31.45 | 2024 | Onpattro |
| Bard Peripheral Vascular, INC. | $31.44 | 2022-2024 | Rotarexs 6 F X 135 Cm |
| Cvrx, INC. | $28.58 | 2025 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $23.87 | 2024 | |
| Cordis US Corp. | $23.42 | 2022 | |
| Inspire Medical Systems, INC. | $22.94 | 2024 | Inspire |
| Azurity Pharmaceuticals, INC. | $22.53 | 2025 | Edarbi |
| Philips North America LLC | $21.50 | 2022 | |
| Surmodics, INC. | $16.90 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Novo Nordisk INC | $16.41 | 2025 | Ozempic |
| Scpharmaceuticals INC. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bromet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.